Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

[Japon] A tale of two Japanese drugs in tests to fight COVID-19

Auteur : Rocky Swift, Christine Soares (Additional reporting by Sangmi Cha in Seoul; Editing by Elyse Tanouye and Carmel Crimmins).

Production : Reuters, agence de presse mondiale et généraliste fondée en 1851 à Londres.

Diffusion : site de Reuters

Date : 13 mai 2020

In the global hunt for coronavirus treatments, a Japanese antiviral medicine known as Avigan has won plaudits from Prime Minister Shinzo Abe and $128 million in government funding.

Source : Rocky Swift, Christine Soares, « A tale of two Japanese drugs in tests to fight COVID-19 », Reuters, 13/05/2020. URL : https://www.reuters.com/article/us-health-coronavirus-japan-medicine/a-tale-of-two-japanese-drugs-in-tests-to-fight-covid-19-idUSKBN22O3DC (consulté le 13/05/2020).

Photo « à la une » : Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm’s headquarters in Tokyo October 22, 2014. © Reuters / Issei Kato


OpenEdition vous propose de citer ce billet de la manière suivante :
IAOdocJ (13 mai 2020). [Japon] A tale of two Japanese drugs in tests to fight COVID-19. Asie Orientale et Coronavirus. Consulté le 24 mai 2025 à l’adresse https://doi.org/10.58079/n788


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.